ask="6.85"
ask_size="100"
average_daily_volume="135523"
bid="5.65"
bid_size="100"
book_value="3.29"
change="-0.15"
change_from_200_day_moving_average="-3.25"
change_from_50_day_moving_average="0.91"
change_from_52_week_high="-11.15"
change_From_52_week_low="2.05"
change_in_percent="-2.24%"
close="6.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.55"
ebitda="-19.45M"
eps_estimate_current_year="-2.83"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.75"
high_52_weeks="17.70"
last_trade_date="2/21/2017"
last_trade_price="6.55"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.40"
low_52_weeks="4.50"
market_capitalization="51.20M"
moving_average_200_day="9.80"
moving_average_50_day="5.64"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.88"
open="6.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.15%"
percent_change_from_50_day_moving_average="+16.11%"
percent_change_from_52_week_high="-62.99%"
percent_change_from_52_week_low="+45.56%"
previous_close="6.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.04"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.30"
stock_exchange="NCM"
symbol="TRIL"
volume="98920"
weeks_range_52="4.50 - 17.70"
